KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacific Biosciences Of California (PACB) Return on Invested Capital (2022 - 2025)

Pacific Biosciences Of California has reported Return on Invested Capital over the past 4 years, most recently at 26.75% for Q4 2025.

  • Quarterly results put Return on Invested Capital at 26.75% for Q4 2025, down 2576.0% from a year ago — trailing twelve months through Dec 2025 was 26.75% (down 2576.0% YoY), and the annual figure for FY2025 was 2.17%, down 138.0%.
  • Return on Invested Capital for Q4 2025 was 26.75% at Pacific Biosciences Of California, down from 13.66% in the prior quarter.
  • Over the last five years, Return on Invested Capital for PACB hit a ceiling of 0.33% in Q3 2023 and a floor of 26.75% in Q4 2025.
  • Median Return on Invested Capital over the past 4 years was 0.86% (2024), compared with a mean of 5.13%.
  • Biggest five-year swings in Return on Invested Capital: increased 11bps in 2023 and later tumbled -2576bps in 2025.
  • Pacific Biosciences Of California's Return on Invested Capital stood at 0.44% in 2022, then grew by 5bps to 0.41% in 2023, then tumbled by -140bps to 0.99% in 2024, then crashed by -2603bps to 26.75% in 2025.
  • The last three reported values for Return on Invested Capital were 26.75% (Q4 2025), 13.66% (Q3 2025), and 9.02% (Q2 2025) per Business Quant data.